Global Antibody Drug Conjugates Market 2024-2028

Global Antibody Drug Conjugates Market 2024-2028


The antibody drug conjugates market is forecasted to grow by USD 9.95 bn during 2023-2028, accelerating at a CAGR of 15.06% during the forecast period. The report on the antibody drug conjugates market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer and other diseases, technological advancements in ADC development, and increasing investments in pharmaceutical research and development.

Technavio's antibody drug conjugates market is segmented as below:

By Application
  • Breast cancer
  • Blood cancer
  • Others
By Technology
  • Cleavable linker
  • Non-cleavable linker
  • Linkerless
By Geography
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing adoption and development of targeted therapies as one of the prime reasons driving the antibody drug conjugates market growth during the next few years. Also, advancements in technology and manufacturing processes and increasing demand for personalized medicine in cancer treatment will lead to sizable demand in the market.

The report on the antibody drug conjugates market covers the following areas:
  • Antibody drug conjugates market sizing
  • Antibody drug conjugates market forecast
  • Antibody drug conjugates market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antibody drug conjugates market vendors that include AbbVie Inc., Adcendo ApS, Araris Biotech AG, Astellas Pharma Inc., AstraZeneca Plc, Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., ImmunoGen Inc., Merck KGaA, Mersana Therapeutics Inc., Mythic Therapeutics, Pfizer Inc., Piramal Enterprises Ltd., PPF Group, Regeneron Pharmaceuticals Inc., Seagen Inc., Syngene International Ltd., Takeda Pharmaceutical Co. Ltd., and ADC Therapeutics SA. Also, the antibody drug conjugates market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


  • Executive Summary
    • Market overview
      • Table Executive Summary - Chart on Market Overview
      • Table Executive Summary - Data Table on Market Overview
      • Table Executive Summary - Chart on Global Market Characteristics
      • Table Executive Summary - Chart on Market by Geography
      • Table Executive Summary - Chart on Market Segmentation by Application
      • Table Executive Summary - Chart on Market Segmentation by Technology
      • Table Executive Summary - Chart on Incremental Growth
      • Table Executive Summary - Data Table on Incremental Growth
      • Table Executive Summary - Chart on Vendor Market Positioning
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market Characteristics
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2023
    • Market outlook: Forecast for 2023-2028
      • Table Chart on Global - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Global - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Historic Market Size
    • Global antibody drug conjugates market 2018 - 2022
      • Table Historic Market Size - Data Table on global antibody drug conjugates market 2018 – 2022 ($ million)
    • Application Segment Analysis 2018 - 2022
      • Table Historic Market Size - Application Segment 2018 - 2022 ($ million)
    • Technology Segment Analysis 2018 - 2022
      • Table Historic Market Size - Technology Segment 2018 - 2022 ($ million)
    • Geography Segment Analysis 2018 - 2022
      • Table Historic Market Size - Geography Segment 2018 - 2022 ($ million)
    • Country Segment Analysis 2018 - 2022
      • Table Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis - Comparison between 2023 and 2028
    • Bargaining power of buyers
      • Table Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers - Impact of key factors in 2023 and 2028
    • Threat of new entrants
      • Table Threat of new entrants - Impact of key factors in 2023 and 2028
    • Threat of substitutes
      • Table Threat of substitutes - Impact of key factors in 2023 and 2028
    • Threat of rivalry
      • Table Threat of rivalry - Impact of key factors in 2023 and 2028
    • Market condition
      • Table Chart on Market condition - Five forces 2023 and 2028
  • Market Segmentation by Application
    • Market segments
      • Table Chart on Application - Market share 2023-2028 (%)
      • Table Data Table on Application - Market share 2023-2028 (%)
    • Comparison by Application
      • Table Chart on Comparison by Application
      • Table Data Table on Comparison by Application
    • Breast cancer - Market size and forecast 2023-2028
      • Table Chart on Breast cancer - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Breast cancer - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
    • Blood cancer - Market size and forecast 2023-2028
      • Table Chart on Blood cancer - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Blood cancer - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Blood cancer - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Blood cancer - Year-over-year growth 2023-2028 (%)
    • Others - Market size and forecast 2023-2028
      • Table Chart on Others - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Others - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Others - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Others - Year-over-year growth 2023-2028 (%)
    • Market opportunity by Application
      • Table Market opportunity by Application ($ million)
      • Table Data Table on Market opportunity by Application ($ million)
  • Market Segmentation by Technology
    • Market segments
      • Table Chart on Technology - Market share 2023-2028 (%)
      • Table Data Table on Technology - Market share 2023-2028 (%)
    • Comparison by Technology
      • Table Chart on Comparison by Technology
      • Table Data Table on Comparison by Technology
    • Cleavable linker - Market size and forecast 2023-2028
      • Table Chart on Cleavable linker - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Cleavable linker - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Cleavable linker - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Cleavable linker - Year-over-year growth 2023-2028 (%)
    • Non-cleavable linker - Market size and forecast 2023-2028
      • Table Chart on Non-cleavable linker - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Non-cleavable linker - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
    • Linkerless - Market size and forecast 2023-2028
      • Table Chart on Linkerless - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Linkerless - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Linkerless - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Linkerless - Year-over-year growth 2023-2028 (%)
    • Market opportunity by Technology
      • Table Market opportunity by Technology ($ million)
      • Table Data Table on Market opportunity by Technology ($ million)
  • Customer Landscape
    • Customer landscape overview
      • Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Geographic Landscape
    • Geographic segmentation
      • Table Chart on Market share by geography 2023-2028 (%)
      • Table Data Table on Market share by geography 2023-2028 (%)
    • Geographic comparison
      • Table Chart on Geographic comparison
      • Table Data Table on Geographic comparison
    • North America - Market size and forecast 2023-2028
      • Table Chart on North America - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on North America - Market size and forecast 2023-2028 ($ million)
      • Table Chart on North America - Year-over-year growth 2023-2028 (%)
      • Table Data Table on North America - Year-over-year growth 2023-2028 (%)
    • Europe - Market size and forecast 2023-2028
      • Table Chart on Europe - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Europe - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • Asia - Market size and forecast 2023-2028
      • Table Chart on Asia - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Asia - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • Rest of World (ROW) - Market size and forecast 2023-2028
      • Table Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • US - Market size and forecast 2023-2028
      • Table Chart on US - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on US - Market size and forecast 2023-2028 ($ million)
      • Table Chart on US - Year-over-year growth 2023-2028 (%)
      • Table Data Table on US - Year-over-year growth 2023-2028 (%)
    • Germany - Market size and forecast 2023-2028
      • Table Chart on Germany - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Germany - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • China - Market size and forecast 2023-2028
      • Table Chart on China - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on China - Market size and forecast 2023-2028 ($ million)
      • Table Chart on China - Year-over-year growth 2023-2028 (%)
      • Table Data Table on China - Year-over-year growth 2023-2028 (%)
    • UK - Market size and forecast 2023-2028
      • Table Chart on UK - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on UK - Market size and forecast 2023-2028 ($ million)
      • Table Chart on UK - Year-over-year growth 2023-2028 (%)
      • Table Data Table on UK - Year-over-year growth 2023-2028 (%)
    • Japan - Market size and forecast 2023-2028
      • Table Chart on Japan - Market size and forecast 2023-2028 ($ million)
      • Table Data Table on Japan - Market size and forecast 2023-2028 ($ million)
      • Table Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Table Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
      • Table Data Tables on Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • Growing prevalence of cancer and other diseases
      • Technological advancements in ADC development
    • Market challenges
      • High development costs for antibody drug conjugates
      • Clinical trial challenges
    • Impact of drivers and challenges
      • Table Impact of drivers and challenges in 2023 and 2028
    • Market trends
      • Increasing adoption and development of targeted therapies
      • Advancements in technology and manufacturing processes
  • Vendor Landscape
    • Overview
    • Vendor landscape
      • Table Overview on Criticality of inputs and Factors of differentiation
    • Landscape disruption
      • Table Overview on factors of disruption
    • Industry risks
      • Table Impact of key risks on business
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Matrix on vendor position and classification
    • AbbVie Inc.
      • Table AbbVie Inc. - Overview
      • Table AbbVie Inc. - Product / Service
      • Table AbbVie Inc. - Key news
      • Table AbbVie Inc. - Key offerings
    • ADC Therapeutics SA
      • Table ADC Therapeutics SA - Overview
      • Table ADC Therapeutics SA - Product / Service
      • Table ADC Therapeutics SA - Key offerings
    • Astellas Pharma Inc.
      • Table Astellas Pharma Inc. - Overview
      • Table Astellas Pharma Inc. - Product / Service
      • Table Astellas Pharma Inc. - Key news
      • Table Astellas Pharma Inc. - Key offerings
    • AstraZeneca Plc
      • Table AstraZeneca Plc - Overview
      • Table AstraZeneca Plc - Product / Service
      • Table AstraZeneca Plc - Key news
      • Table AstraZeneca Plc - Key offerings
    • Daiichi Sankyo Co. Ltd.
      • Table Daiichi Sankyo Co. Ltd. - Overview
      • Table Daiichi Sankyo Co. Ltd. - Product / Service
      • Table Daiichi Sankyo Co. Ltd. - Key news
      • Table Daiichi Sankyo Co. Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd.
      • Table F. Hoffmann La Roche Ltd. - Overview
      • Table F. Hoffmann La Roche Ltd. - Business segments
      • Table F. Hoffmann La Roche Ltd. - Key news
      • Table F. Hoffmann La Roche Ltd. - Key offerings
      • Table F. Hoffmann La Roche Ltd. - Segment focus
    • Gilead Sciences Inc.
      • Table Gilead Sciences Inc. - Overview
      • Table Gilead Sciences Inc. - Product / Service
      • Table Gilead Sciences Inc. - Key news
      • Table Gilead Sciences Inc. - Key offerings
    • Merck KGaA
      • Table Merck KGaA - Overview
      • Table Merck KGaA - Business segments
      • Table Merck KGaA - Key news
      • Table Merck KGaA - Key offerings
      • Table Merck KGaA - Segment focus
    • Mersana Therapeutics Inc.
      • Table Mersana Therapeutics Inc. - Overview
      • Table Mersana Therapeutics Inc. - Product / Service
      • Table Mersana Therapeutics Inc. - Key offerings
    • ImmunoGen Inc.
      • Table ImmunoGen Inc. - Overview
      • Table ImmunoGen Inc. - Product / Service
      • Table ImmunoGen Inc. - Key offerings
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Product / Service
      • Table Pfizer Inc. - Key news
      • Table Pfizer Inc. - Key offerings
    • Regeneron Pharmaceuticals Inc.
      • Table Regeneron Pharmaceuticals Inc. - Overview
      • Table Regeneron Pharmaceuticals Inc. - Product / Service
      • Table Regeneron Pharmaceuticals Inc. - Key offerings
    • Seagen Inc.
      • Table Seagen Inc. - Overview
      • Table Seagen Inc. - Product / Service
      • Table Seagen Inc. - Key offerings
    • Syngene International Ltd.
      • Table Syngene International Ltd. - Overview
      • Table Syngene International Ltd. - Product / Service
      • Table Syngene International Ltd. - Key offerings
    • Takeda Pharmaceutical Co. Ltd.
      • Table Takeda Pharmaceutical Co. Ltd. - Overview
      • Table Takeda Pharmaceutical Co. Ltd. - Product / Service
      • Table Takeda Pharmaceutical Co. Ltd. - Key news
      • Table Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Inclusions and exclusions checklist
      • Table Inclusions checklist
      • Table Exclusions checklist
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings